Group One Trading’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,576
| Closed | -$24K | – | 8465 |
|
|
2022
Q3 | $24K | Buy |
1,576
+1,300
| +471% | +$15.1K | ﹤0.01% | 5956 |
|
|
2022
Q2 | $2K | Sell |
276
-924
| -77% | -$6.51K | ﹤0.01% | 7489 |
|
|
2022
Q1 | $11K | Buy |
1,200
+900
| +300% | +$6.94K | ﹤0.01% | 7141 |
|
|
2021
Q4 | $2K | Buy |
+300
| New | +$3.14K | ﹤0.01% | 7947 |
|
|
2020
Q4 | – | Sell |
-42
| Closed | -$508 | – | 7203 |
|
|
2020
Q3 | $0 | Buy |
+42
| New | +$512 | ﹤0.01% | 6721 |
|
|
2020
Q2 | – | Sell |
-242
| Closed | -$3.58K | – | 6364 |
|
|
2020
Q1 | $3K | Sell |
242
-1,883
| -89% | -$35.7K | ﹤0.01% | 4922 |
|
|
2019
Q4 | $51K | Sell |
2,125
-65,809
| -97% | -$1.36M | ﹤0.01% | 4003 |
|
|
2019
Q3 | $1.31M | Sell |
67,934
-879
| -1% | -$20.1K | 0.01% | 1529 |
|
|
2019
Q2 | $2.03M | Buy |
+68,813
| New | +$2.65M | 0.02% | 1074 |
|
|
2017
Q4 | – | Sell |
-281
| Closed | -$17K | – | 5374 |
|
|
2017
Q3 | $14K | Sell |
281
-910
| -76% | -$49.6K | ﹤0.01% | 4203 |
|
|
2017
Q2 | $63K | Sell |
1,191
-591
| -33% | -$27.5K | ﹤0.01% | 3386 |
|
|
2017
Q1 | $81K | Buy |
+1,782
| New | +$79.5K | ﹤0.01% | 3105 |
|
|
2016
Q4 | – | Sell |
-26,971
| Closed | -$1.02M | – | 4965 |
|
|
2016
Q3 | $1.02M | Buy |
+26,971
| New | +$595K | 0.01% | 1272 |
|
|
2016
Q1 | – | Sell |
-4,715
| Closed | -$74.6K | – | 5094 |
|
|
2015
Q4 | $115K | Sell |
4,715
-39,127
| -89% | -$913K | ﹤0.01% | 2897 |
|
|
2015
Q3 | $778K | Buy |
43,842
+31,828
| +265% | +$576K | 0.01% | 1431 |
|
|
2015
Q2 | $212K | Buy |
+12,014
| New | +$220K | ﹤0.01% | 2482 |
|
Group One Trading's AERI Position: Q4 2022 in Review
Group One Trading sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 1,576 shares — an estimated $24K sold.
Group One Trading first reported a position in AERI in Q2 2015 and held it in 16 quarters. The position peaked at $2.03M in Q2 2019. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.
- Group One Trading reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
- Group One Trading sold 1,576 Aerie Pharmaceuticals shares in Q4 2022, an estimated $24K.
- Group One Trading first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 16 quarters.
- Group One Trading's Aerie Pharmaceuticals position peaked at $2.03M in Q2 2019.
- 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.